A bedside guide to defining the problem space before deciding how to reason or act
How to use this guide
This is a rapid point-of-care orientation tool.
It helps you answer:
What kind of problem space am I in right now?
Within Consult Practice:
- Orientation defines the map
- Thinking determines stance within that map
- Execution translates that stance into visible action and communication
This guide clarifies what kinds of danger are plausible and how urgent the moment may be.
It does not diagnose and does not instruct management.
If you finish this guide knowing what to do, it has gone too far.
Once the problem space is defined, Thinking assigns weight to the dangers, and Execution translates that posture into action and communication.
What “problem space” means
A problem space describes:
- what kinds of explanations are plausible,
- what kinds of danger must be considered,
- how much uncertainty can safely be tolerated,
- and how quickly the situation may evolve.
Two patients with similar laboratory findings may occupy very different terrains depending on clinical stability, trajectory, and context.
Orientation explains that difference.
Relationship to reference resources
Protocols and reference texts assume the problem space has already been defined.
Orientation helps determine whether this laboratory pattern suggests:
- acute red cell destruction with immediate physiologic risk,
- a chronic or compensated hemolytic process,
- or a physiologic or pathologic mimic that requires clarification rather than escalation.
It is complementary, not competitive.
Universal first check
Before framing the situation:
- confirm the hemoglobin trajectory (how fast, how far),
- assess clinical stability and physiologic reserve,
- exclude active bleeding,
- review whether the LDH, bilirubin, and haptoglobin pattern is compatible with hemolysis, without assuming it proves hemolysis,
- if a smear is already available, scan only for pattern-level signals that would change the terrain (supportive vs not supportive), without naming a cause.
This is about defining the world the patient is in, not diagnosing why.
Hemolysis is a pattern-recognition consult.
The first danger is often missed time-critical physiology (rapid hemoglobin fall, hemoglobinuria, acute kidney injury, shock) or misread artifacts and mimics that falsely suggest destruction.
The two-axis map (tempo × physiologic threat)
Most suspected hemolysis consults fall into one of four functional worlds:
- acute + unstable → immediate physiologic danger terrain
- acute + stable → high-vigilance evolving terrain
- chronic + stable → compensated baseline terrain
- unclear tempo → ambiguity terrain (hold multiple worlds until trajectory clarifies)
This map defines urgency and uncertainty tolerance before mechanism.
Core orientation lenses
These are orients, not steps.
They do not need to be addressed in order.
Each one constrains plausible explanations and urgency.
Orient 1 — How dangerous could this be right now?
A falling hemoglobin with hemolytic markers can represent:
- an acute physiologic threat,
- a stable but evolving process,
- or a contained and chronic state.
This orient constrains urgency, not management.
Orient 2 — Is the pattern consistent with true red cell destruction, or could it be a mimic?
Elevated LDH and indirect bilirubin may arise from:
- hemolysis,
- liver disease,
- recent transfusion,
- tissue injury, or
- other physiologic stress.
You are defining whether hemolysis is plausible in the terrain, not whether it is present.
Orient 3 — Is the anemia isolated or part of a broader hematologic pattern?
Look for:
- thrombocytopenia,
- leukopenia,
- or pancytopenia.
Isolated anemia defines a different terrain from anemia coupled to multi-lineage abnormalities.
Orient 4 — Does the clinical context suggest a systemic danger terrain?
Some settings raise concern that anemia reflects a broader, high-risk physiologic process:
- critical illness or sepsis,
- pregnancy or postpartum state,
- malignancy or transplant,
- recent transfusion,
- new or high-risk medications,
- mechanical circulatory devices or vascular stress states.
The purpose is not to name a mechanism.
It is to decide whether this anemia signal may be coupled to a systemic process where delay carries asymmetric harm.
Orient 5 — What does the tempo suggest?
Rapid decline implies an evolving, high-risk terrain.
Stable values imply a contained or compensated world.
Orientation defines tempo expectations, not behavior.
Orient 6 — Is compensation present or absent?
Ask whether the marrow response appears appropriate for the degree of anemia.
Absent or blunted compensation suggests a different terrain (production-limited or systemic suppression) than a high-turnover destruction world.
This defines whether you are in a destruction-dominant vs production-limited terrain, without naming causes.
Concrete comparison
| Patient | Hemoglobin | Context | Trajectory | Problem Space |
|---|---|---|---|---|
| A | 8 g/dL | Chronic hemolytic anemia | Stable | chronic compensated terrain |
| B | 8 g/dL | Previously normal counts | Falling rapidly with rising LDH and bilirubin | acute destruction terrain requiring vigilance |
| C | 8 g/dL | Critical illness or liver disease | Stable | mimic / ambiguity terrain, clarify before escalation |
Same laboratory pattern.
Different terrain.
Orientation explains why.
Common traps to avoid
- equating abnormal markers with confirmed hemolysis
- assuming the anemia must be unified early
- escalating before clinical stability and tempo are known
- reassuring prematurely based on appearance alone
- ignoring trajectory
- confusing physiologic compensation with clinical safety
Orientation protects against these early errors.
Functional problem spaces this guide identifies
This guide helps determine whether you are in:
- immediate physiologic danger terrain
- plausible destruction terrain requiring vigilance
- chronic compensated terrain
- multi-process marrow or systemic terrain
- ambiguity terrain requiring surveillance
Each will demand a different Thinking and Execution posture.
Bottom line
Suspected hemolysis is not a diagnosis.
Orientation answers:
- how dangerous this situation might be,
- how broad the terrain is,
- how quickly physiology may change,
- and how much uncertainty the moment can tolerate.
Define the map first.
Then engage:
➡️ Thinking for cognitive stance
➡️ Execution for visible action and communication
Terms used in this guide
A short decoder for the language above.
Problem space (terrain)
the clinical “world” the patient is in right now, defined by what kinds of danger are plausible, how fast things may evolve, and how much uncertainty is safe.
Terrain
shorthand for problem space, used to emphasize that the same lab pattern can belong to different clinical worlds depending on context and trajectory.
Tempo
how fast the picture is changing, usually anchored to the hemoglobin trajectory and the pace of physiologic change (hours to days, not weeks).
Physiologic threat
evidence that the anemia or hemolysis pattern is stressing the body now (for example, hemodynamic instability, shock physiology, hemoglobinuria with kidney injury).
Physiologic reserve
how much buffering capacity the patient has, shaped by baseline cardiopulmonary disease, age, comorbidity, and current illness severity.
Mimic
a process that produces “hemolysis-like” markers (LDH, bilirubin changes, low haptoglobin) without meaningful red-cell destruction driving the clinical risk.
Artifact
a misleading result caused by how the sample was drawn, handled, or measured (for example, in vitro hemolysis), rather than the patient’s physiology.
Pattern-recognition consult
a consult where safety depends on correctly classifying what the pattern means (true destruction vs mimic, acute vs chronic, stable vs unstable) before naming a cause.
Two-axis map (tempo × physiologic threat)
a compact way to classify suspected hemolysis into four functional worlds based on (1) how fast things are changing and (2) whether physiology is threatened now.
Ambiguity terrain
a world where tempo or meaning is unclear, so the safe posture is to hold multiple frames provisionally and let trajectory resolve the uncertainty.
Compensated baseline terrain
a stable world where abnormal hemolysis markers or anemia are long-standing and the patient is adapted, so urgency is usually lower unless trajectory changes.
High-vigilance evolving terrain
a world where physiology is stable but the trajectory suggests the picture may declare itself quickly, so uncertainty tolerance is low and reassessment is central.
Destruction-dominant (frame)
a way of describing a world where red-cell destruction is plausibly driving the anemia and risk, without committing to a specific mechanism.
Production-limited (frame)
a way of describing a world where the marrow response is absent or blunted for the degree of anemia, suggesting impaired production or systemic suppression may be central.
Internal consistency
when multiple data points tell the same story (for example, a falling hemoglobin plus compatible marker pattern plus smear signals), increasing confidence that the terrain is real.
Uncertainty tolerance
how much “not knowing yet” is safe in the next several hours, determined by tempo and physiologic threat, not by curiosity about diagnosis.